0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-4I12362
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global DNA Vaccines Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global DNA Vaccines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-4I12362
Report
September 2022
108 Pages
QYResearch
Region: Global
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
The DNA vaccine in this report refers to the vaccines manufactured using recombinant DNA technology. The advent of these vaccines has revolutionized the healthcare market. These vaccines are more effective, as well as have less side-effects associated with them as compared to traditional vaccines.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global DNA Vaccines market is projected to reach US$ 7849.6 million by 2028 from an estimated US$ 5029.8 million in 2022, at a CAGR of 7.7% during 2023 and 2028.

Global direct-to-consumer genetic testing main players include Merck, GSK, Sanofi, Zoties, Elanco, Boehringer-Ingelheim, Indian Immunologicals and Plumbline Life Sciences, etc., totally accounting for about 50% of the market. North America is the largest market, with a share over 95%. As for the types of products, it can be divided into recombinant protein vaccine and gene-based vaccine. The most common product is recombinant protein, with a share over 95%. In terms of applications, it is widely used in human and animal. Human is the largest application, holding a share over 95%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding DNA Vaccines.
The DNA Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global DNA Vaccines market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
Product Type Insights
Global markets are presented by DNA Vaccines type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the DNA Vaccines are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

DNA Vaccines Segment by Type

Recombinant Protein Vaccine
Gene-Based Vaccine
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the DNA Vaccines market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the DNA Vaccines market.

DNA Vaccines Segment by Application

Human
Animal
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the DNA Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of DNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the DNA Vaccines industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Vaccines

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 DNA Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global DNA Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Recombinant Protein Vaccine
1.2.3 Gene-Based Vaccine
1.3 Market by Application
1.3.1 Global DNA Vaccines Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Human
1.3.3 Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global DNA Vaccines Market Size Estimates and Forecasts
2.1.1 Global DNA Vaccines Revenue 2017-2028
2.1.2 Global DNA Vaccines Sales 2017-2028
2.2 DNA Vaccines Market Size by Region: 2022 Versus 2028
2.3 DNA Vaccines Sales by Region (2017-2028)
2.3.1 Global DNA Vaccines Sales by Region: 2017-2022
2.3.2 Global DNA Vaccines Sales Forecast by Region (2023-2028)
2.3.3 Global DNA Vaccines Sales Market Share by Region (2017-2028)
2.4 DNA Vaccines Market Estimates and Projections by Region (2023-2028)
2.4.1 Global DNA Vaccines Revenue by Region: 2017-2022
2.4.2 Global DNA Vaccines Revenue Forecast by Region (2023-2028)
2.4.3 Global DNA Vaccines Revenue Market Share by Region (2017-2028)
3 Global DNA Vaccines by Manufacturers
3.1 Global Top DNA Vaccines Manufacturers by Sales
3.1.1 Global DNA Vaccines Sales by Manufacturer (2017-2022)
3.1.2 Global DNA Vaccines Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top DNA Vaccines Manufacturers by Revenue
3.2.1 Global DNA Vaccines Revenue by Manufacturer (2017-2022)
3.2.2 Global DNA Vaccines Revenue Share by Manufacturer (2017-2022)
3.3 Global DNA Vaccines Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key DNA Vaccines Manufacturers Covered: Ranking by Revenue
3.4.2 Global DNA Vaccines Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global DNA Vaccines Manufacturing Base Distribution, Product Type
3.5.1 DNA Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers DNA Vaccines Product Type
3.5.3 Date of International Manufacturers Enter into DNA Vaccines Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Corporation Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck DNA Vaccines Products Offered
4.1.4 Merck DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Merck DNA Vaccines Sales by Product in 2021
4.1.6 Merck DNA Vaccines Sales by Application in 2021
4.1.7 Merck DNA Vaccines Sales by Geographic Area in 2021
4.1.8 Merck Recent Developments
4.2 GSK
4.2.1 GSK Corporation Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK DNA Vaccines Products Offered
4.2.4 GSK DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.2.5 GSK DNA Vaccines Sales by Product in 2021
4.2.6 GSK DNA Vaccines Sales by Application in 2021
4.2.7 GSK DNA Vaccines Sales by Geographic Area in 2021
4.2.8 GSK Recent Developments
4.3 Sanofi
4.3.1 Sanofi Corporation Information
4.3.2 Sanofi Description, Business Overview
4.3.3 Sanofi DNA Vaccines Products Offered
4.3.4 Sanofi DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Sanofi DNA Vaccines Sales by Product in 2021
4.3.6 Sanofi DNA Vaccines Sales by Application in 2021
4.3.7 Sanofi DNA Vaccines Sales by Geographic Area in 2021
4.3.8 Sanofi Recent Developments
4.4 Zoties
4.4.1 Zoties Corporation Information
4.4.2 Zoties Description, Business Overview
4.4.3 Zoties DNA Vaccines Products Offered
4.4.4 Zoties DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Zoties DNA Vaccines Sales by Product in 2021
4.4.6 Zoties DNA Vaccines Sales by Application in 2021
4.4.7 Zoties DNA Vaccines Sales by Geographic Area in 2021
4.4.8 Zoties Recent Developments
4.5 Elanco
4.5.1 Elanco Corporation Information
4.5.2 Elanco Description, Business Overview
4.5.3 Elanco DNA Vaccines Products Offered
4.5.4 Elanco DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Elanco DNA Vaccines Sales by Product in 2021
4.5.6 Elanco DNA Vaccines Sales by Application in 2021
4.5.7 Elanco DNA Vaccines Sales by Geographic Area in 2021
4.5.8 Elanco Recent Developments
4.6 Boehringer-Ingelheim
4.6.1 Boehringer-Ingelheim Corporation Information
4.6.2 Boehringer-Ingelheim Description, Business Overview
4.6.3 Boehringer-Ingelheim DNA Vaccines Products Offered
4.6.4 Boehringer-Ingelheim DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Boehringer-Ingelheim DNA Vaccines Sales by Product in 2021
4.6.6 Boehringer-Ingelheim DNA Vaccines Sales by Application in 2021
4.6.7 Boehringer-Ingelheim DNA Vaccines Sales by Geographic Area in 2021
4.6.8 Boehringer-Ingelheim Recent Development
4.7 Indian Immunologicals
4.7.1 Indian Immunologicals Corporation Information
4.7.2 Indian Immunologicals Description, Business Overview
4.7.3 Indian Immunologicals DNA Vaccines Products Offered
4.7.4 Indian Immunologicals DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Indian Immunologicals DNA Vaccines Sales by Product in 2021
4.7.6 Indian Immunologicals DNA Vaccines Sales by Application in 2021
4.7.7 Indian Immunologicals DNA Vaccines Sales by Geographic Area in 2021
4.7.8 Indian Immunologicals Recent Development
4.8 Plumbline Life Sciences
4.8.1 Plumbline Life Sciences Corporation Information
4.8.2 Plumbline Life Sciences Description, Business Overview
4.8.3 Plumbline Life Sciences DNA Vaccines Products Offered
4.8.4 Plumbline Life Sciences DNA Vaccines Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Plumbline Life Sciences DNA Vaccines Sales by Product in 2021
4.8.6 Plumbline Life Sciences DNA Vaccines Sales by Application in 2021
4.8.7 Plumbline Life Sciences DNA Vaccines Sales by Geographic Area in 2021
4.8.8 Plumbline Life Sciences Recent Development
5 Breakdown Data by Type
5.1 Global DNA Vaccines Sales by Type (2017-2028)
5.1.1 Global DNA Vaccines Sales by Type (2017-2022)
5.1.2 Global DNA Vaccines Sales Forecast by Type (2023-2028)
5.1.3 Global DNA Vaccines Sales Market Share by Type (2017-2028)
5.2 Global DNA Vaccines Revenue Forecast by Type (2017-2028)
5.2.1 Global DNA Vaccines Revenue by Type (2017-2022)
5.2.2 Global DNA Vaccines Revenue Forecast by Type (2023-2028)
5.2.3 Global DNA Vaccines Revenue Market Share by Type (2017-2028)
5.3 DNA Vaccines Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global DNA Vaccines Sales by Application (2017-2028)
6.1.1 Global DNA Vaccines Sales by Application (2017-2022)
6.1.2 Global DNA Vaccines Sales Forecast by Application (2023-2028)
6.1.3 Global DNA Vaccines Sales Market Share by Application (2017-2028)
6.2 Global DNA Vaccines Revenue Forecast by Application (2017-2028)
6.2.1 Global DNA Vaccines Revenue by Application (2017-2022)
6.2.2 Global DNA Vaccines Revenue Forecast by Application (2023-2028)
6.2.3 Global DNA Vaccines Revenue Market Share by Application (2017-2028)
6.3 DNA Vaccines Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America DNA Vaccines Market Size YoY Growth 2017-2028
7.2 North America DNA Vaccines Market Facts & Figures by Country
7.2.1 North America DNA Vaccines Sales by Country (2017-2028)
7.2.2 North America DNA Vaccines Revenue by Country (2017-2028)
7.3 North America DNA Vaccines Sales by Type
7.4 North America DNA Vaccines Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific DNA Vaccines Market Size YoY Growth 2017-2028
8.2 Asia-Pacific DNA Vaccines Market Facts & Figures by Region
8.2.1 Asia-Pacific DNA Vaccines Sales by Region (2017-2028)
8.2.2 Asia-Pacific DNA Vaccines Revenue by Region (2017-2028)
8.3 Asia-Pacific DNA Vaccines Sales by Type
8.4 Asia-Pacific DNA Vaccines Sales by Application
9 Europe
9.1 Europe DNA Vaccines Market Size YoY Growth 2017-2028
9.2 Europe DNA Vaccines Market Facts & Figures by Country
9.2.1 Europe DNA Vaccines Sales by Country (2017-2028)
9.2.2 Europe DNA Vaccines Revenue by Country (2017-2028)
9.3 Europe DNA Vaccines Sales by Type
9.4 Europe DNA Vaccines Sales by Application
10 Latin America
10.1 Latin America DNA Vaccines Market Size YoY Growth 2017-2028
10.2 Latin America DNA Vaccines Market Facts & Figures by Country
10.2.1 Latin America DNA Vaccines Sales by Country (2017-2028)
10.2.2 Latin America DNA Vaccines Revenue by Country (2017-2028)
10.3 Latin America DNA Vaccines Sales by Type
10.4 Latin America DNA Vaccines Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa DNA Vaccines Market Size YoY Growth 2017-2028
11.2 Middle East and Africa DNA Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa DNA Vaccines Sales by Country (2017-2028)
11.2.2 Middle East and Africa DNA Vaccines Revenue by Country (2017-2028)
11.3 Middle East and Africa DNA Vaccines Sales by Type
11.4 Middle East and Africa DNA Vaccines Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 DNA Vaccines Supply Chain Analysis
12.2 DNA Vaccines Key Raw Materials and Upstream Suppliers
12.3 DNA Vaccines Clients Analysis
12.4 DNA Vaccines Sales Channel and Sales Model Analysis
12.4.1 DNA Vaccines Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 DNA Vaccines Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 DNA Vaccines Distributors
13 Market Dynamics
13.1 DNA Vaccines Industry Trends
13.2 DNA Vaccines Market Drivers
13.3 DNA Vaccines Market Challenges
13.4 DNA Vaccines Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global DNA Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Recombinant Protein Vaccine
    Table 3. Major Manufacturers of Gene-Based Vaccine
    Table 4. Global DNA Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global DNA Vaccines Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 6. Global DNA Vaccines Sales by Region (2017-2022) & (K Units)
    Table 7. Global DNA Vaccines Sales Forecast by Region (2023-2028) & (K Units)
    Table 8. Global DNA Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global DNA Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Global DNA Vaccines Sales by Manufacturer (2017-2022) & (K Units)
    Table 11. Global DNA Vaccines Sales Share by Manufacturer (2017-2022)
    Table 12. DNA Vaccines Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 13. DNA Vaccines Revenue Share by Manufacturer (2017-2022)
    Table 14. Key Manufacturers DNA Vaccines Price (2017-2022) & (USD/Unit)
    Table 15. Ranking of Global Top DNA Vaccines Manufacturers by Revenue (US$ Million) in 2021
    Table 16. Global DNA Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 17. Global DNA Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in DNA Vaccines as of 2021)
    Table 18. DNA Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers DNA Vaccines Product Type
    Table 20. Date of International Manufacturers Enter into DNA Vaccines Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Merck Corporation Information
    Table 23. Merck Description and Business Overview
    Table 24. Merck DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 25. Merck DNA Vaccines Product
    Table 26. Merck DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 27. Merck DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 28. Merck DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 29. Merck Recent Development
    Table 30. GSK Corporation Information
    Table 31. GSK Description and Business Overview
    Table 32. GSK DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 33. GSK DNA Vaccines Product
    Table 34. GSK DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 35. GSK DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 36. GSK DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 37. GSK Recent Development
    Table 38. Sanofi Corporation Information
    Table 39. Sanofi Description and Business Overview
    Table 40. Sanofi DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 41. Sanofi DNA Vaccines Product
    Table 42. Sanofi DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 43. Sanofi DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 44. Sanofi DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 45. Sanofi Recent Development
    Table 46. Zoties Corporation Information
    Table 47. Zoties Description and Business Overview
    Table 48. Zoties DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 49. Zoties DNA Vaccines Product
    Table 50. Zoties DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 51. Zoties DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 52. Zoties DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 53. Zoties Recent Development
    Table 54. Elanco Corporation Information
    Table 55. Elanco Description and Business Overview
    Table 56. Elanco DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. Elanco DNA Vaccines Product
    Table 58. Elanco DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 59. Elanco DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 60. Elanco DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 61. Elanco Recent Development
    Table 62. Boehringer-Ingelheim Corporation Information
    Table 63. Boehringer-Ingelheim Description and Business Overview
    Table 64. Boehringer-Ingelheim DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Boehringer-Ingelheim DNA Vaccines Product
    Table 66. Boehringer-Ingelheim DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 67. Boehringer-Ingelheim DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 68. Boehringer-Ingelheim DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 69. Indian Immunologicals Corporation Information
    Table 70. Indian Immunologicals Description and Business Overview
    Table 71. Indian Immunologicals DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 72. Indian Immunologicals DNA Vaccines Product
    Table 73. Indian Immunologicals DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 74. Indian Immunologicals DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 75. Indian Immunologicals DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 76. Plumbline Life Sciences Corporation Information
    Table 77. Plumbline Life Sciences Description and Business Overview
    Table 78. Plumbline Life Sciences DNA Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 79. Plumbline Life Sciences DNA Vaccines Product
    Table 80. Plumbline Life Sciences DNA Vaccines Sales Proportion of DNA Vaccines by Product in 2021
    Table 81. Plumbline Life Sciences DNA Vaccines Sales Proportion of DNA Vaccines by Application in 2021
    Table 82. Plumbline Life Sciences DNA Vaccines Sales Proportion of DNA Vaccines by Geographic Area in 2021
    Table 83. Global DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 84. Global DNA Vaccines Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global DNA Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Global DNA Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 87. Global DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 88. Global DNA Vaccines Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global DNA Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Global DNA Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 91. North America DNA Vaccines Sales by Country (2017-2022) & (K Units)
    Table 92. North America DNA Vaccines Sales by Country (2023-2028) & (K Units)
    Table 93. North America DNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 94. North America DNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 95. North America DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 96. North America DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 97. Asia-Pacific DNA Vaccines Sales by Region (2017-2022) & (K Units)
    Table 98. Asia-Pacific DNA Vaccines Sales by Region (2023-2028) & (K Units)
    Table 99. Asia-Pacific DNA Vaccines Revenue by Region (2017-2028) & (US$ Million)
    Table 100. Asia-Pacific DNA Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 101. Asia-Pacific DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 102. Asia-Pacific DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 103. Europe DNA Vaccines Sales by Country (2017-2022) & (K Units)
    Table 104. Europe DNA Vaccines Sales by Country (2023-2028) & (K Units)
    Table 105. Europe DNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Europe DNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Europe DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 108. Europe DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 109. Latin America DNA Vaccines Sales by Country (2017-2022) & (K Units)
    Table 110. Latin America DNA Vaccines Sales by Country (2023-2028) & (K Units)
    Table 111. Latin America DNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 112. Latin America DNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 113. Latin America DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 114. Latin America DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 115. Middle East and Africa DNA Vaccines Sales by Country (2017-2022) & (K Units)
    Table 116. Middle East and Africa DNA Vaccines Sales by Country (2023-2028) & (K Units)
    Table 117. Middle East and Africa DNA Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 118. Middle East and Africa DNA Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 119. Middle East and Africa DNA Vaccines Sales by Type (2017-2022) & (K Units)
    Table 120. Middle East and Africa DNA Vaccines Sales by Application (2017-2022) & (K Units)
    Table 121. DNA Vaccines Key Raw Materials, Industry Status and Trend
    Table 122. DNA Vaccines Key Raw Materials and Upstream Suppliers
    Table 123. DNA Vaccines Clients Status and Trend
    Table 124. DNA Vaccines Typical Clients
    Table 125. DNA Vaccines Distributors
    Table 126. DNA Vaccines Market Trends
    Table 127. DNA Vaccines Market Drivers
    Table 128. DNA Vaccines Market Challenges
    Table 129. DNA Vaccines Market Restraints
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. DNA Vaccines Product Picture
    Figure 2. Global DNA Vaccines Sales Market Share by Type in 2021 & 2028
    Figure 3. Recombinant Protein Vaccine Product Picture
    Figure 4. Gene-Based Vaccine Product Picture
    Figure 5. Global DNA Vaccines Sales Market Share by Application in 2021 & 2028
    Figure 6. Human Examples
    Figure 7. Animal Examples
    Figure 8. DNA Vaccines Report Years Considered
    Figure 9. Global DNA Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global DNA Vaccines Market Size 2017-2028 (US$ Million)
    Figure 11. Global DNA Vaccines Sales 2017-2028 (K Units)
    Figure 12. Global DNA Vaccines Market Size Market Share by Region: 2022 Versus 2028
    Figure 13. Global DNA Vaccines Sales Market Share Forecast by Region (2017-2028)
    Figure 14. Global DNA Vaccines Revenue Market Share by Region (2017-2028)
    Figure 15. Global DNA Vaccines Sales Share by Manufacturer in 2021
    Figure 16. DNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global DNA Vaccines Sales Market Share Forecast by Type (2017-2028)
    Figure 18. Global DNA Vaccines Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. DNA Vaccines Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
    Figure 20. Global DNA Vaccines Sales Market Share Forecast by Application (2017-2028)
    Figure 21. Global DNA Vaccines Revenue Market Share Forecast by Application (2017-2028)
    Figure 22. DNA Vaccines Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
    Figure 23. North America DNA Vaccines Revenue 2017-2028 (US$ Million)
    Figure 24. North America DNA Vaccines Sales Market Share by Type (2017-2022)
    Figure 25. North America DNA Vaccines Sales Market Share by Application (2017-2022)
    Figure 26. Asia-Pacific DNA Vaccines Revenue 2017-2028 (US$ Million)
    Figure 27. Asia-Pacific DNA Vaccines Sales Market Share by Region (2017-2028)
    Figure 28. Asia-Pacific DNA Vaccines Revenue Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific DNA Vaccines Sales Market Share by Type (2017-2022)
    Figure 30. Asia-Pacific DNA Vaccines Sales Market Share by Application (2017-2022)
    Figure 31. Europe DNA Vaccines Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Europe DNA Vaccines Sales Market Share by Country (2017-2028)
    Figure 33. Europe DNA Vaccines Revenue Market Share by Country (2017-2028)
    Figure 34. Europe DNA Vaccines Sales Market Share by Type (2017-2022)
    Figure 35. Europe DNA Vaccines Sales Market Share by Application (2017-2022)
    Figure 36. Latin America DNA Vaccines Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 37. Latin America DNA Vaccines Sales Market Share by Country (2017-2028)
    Figure 38. Latin America DNA Vaccines Revenue Market Share by Country (2017-2022)
    Figure 39. Latin America DNA Vaccines Sales Market Share by Type (2017-2022)
    Figure 40. Latin America DNA Vaccines Sales Market Share by Application (2017-2022)
    Figure 41. Middle East and Africa DNA Vaccines Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 42. Middle East and Africa DNA Vaccines Sales Market Share by Country (2017-2028)
    Figure 43. Middle East and Africa DNA Vaccines Revenue Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa DNA Vaccines Sales Market Share by Type (2017-2022)
    Figure 45. Middle East and Africa DNA Vaccines Sales Market Share by Application (2017-2022)
    Figure 46. DNA Vaccines Supply Chain (Upstream and Downstream Market)
    Figure 47. Global Production Market Share of DNA Vaccines Raw Materials by Region in 2021
    Figure 48. DNA Vaccines Distribution Channels
    Figure 49. Global DNA Vaccines Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 50. Global DNA Vaccines Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$5900
This license allows only one user to access the PDF.

Electronic (PDF)
$8850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$11800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Lukasiewicz Research Network
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Human Vaccine Adjuvants Market Insights and Forecast to 2028
Global Human Vaccine Adjuvants Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-16A8759
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Global C Difficile Infection Drug Market Insights and Forecast to 2028
Global C Difficile Infection Drug Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-28U8498
Fri Oct 21 00:00:00 UTC 2022

Add to Cart

Global Child Cough Syrup Market Research Report 2022
Global Child Cough Syrup Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-26U12048
Fri Oct 21 00:00:00 UTC 2022

Add to Cart

Global Listeria Monocytogenes Test Kit Market Research Report 2022
Global Listeria Monocytogenes Test Kit Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-27Q12096
Fri Oct 21 00:00:00 UTC 2022

Add to Cart